Pathological Response in Patients With Large Unresected Intermediate- or High-Grade Soft Tissue Sarcoma Receiving Preoperative Chemoradiotherapy ± Pazopanib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pathological Response in Children and Adults With Large Unresected Intermediate-Grade or High-Grade Soft Tissue Sarcoma Receiving Preoperative Chemoradiotherapy With or Without Pazopanib (ARST1321): A Multicentre, Randomised, Open-Label, Phase 2 Trial
Lancet Oncol 2020 Jul 20;[EPub Ahead of Print], AR Weiss, YL Chen, TJ Scharschmidt, YY Chi, J Tian, JO Black, JL Davis, JC Fanburg-Smith, E Zambrano, J Anderson, R Arens, O Binitie, E Choy, JW Davis, A Hayes-Jordan, SC Kao, ML Kayton, S Kessel, R Lim, WH Meyer, L Million, SH Okuno, A Ostrenga, MT Parisi, DA Pryma, RL Randall, MA Rosen, M Schlapkohl, BL Shulkin, EA Smith, JI Sorger, S Terezakis, DS Hawkins, SL Spunt, D WangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.